20 reports

  • Interleukin
  • Interleukin Sales Volume (Million Yuan)
  • Interleukin
  • China
  • Demand
  • Harbin Pharmaceutical Group
  • North China Pharmaceutical Group Corp.
  • Interleukin Sales Volume (Million Yuan)
  • Interleukin Sales Volume (Million Yuan)
  • Interleukin
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • DF-2755A - DRUG PROFILE
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • Cytokine
  • Interleukin
  • United States
  • Product Initiative
  • Dompe Farmaceutici S.p.A.
  • Interleukin Genetics Inc, Key Competitors
  • Interleukin Genetics Inc, Key Employees
  • Biological Therapy
  • Interleukin
  • United States
  • Company Operations
  • Interleukin Genetics, Inc.
  • Interleukin 15 (IL15) - Dormant Projects
  • Interleukin 15 (IL15) - Drug Profiles
  • Digestive System Disorder
  • Interleukin
  • United States
  • World
  • Product Initiative
  • Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) Overview
  • Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Dormant Projects
  • Autoimmune Disease
  • Interleukin
  • World
  • Product Initiative
  • Novartis AG
  • Interleukin 13 (IL13) - Discontinued Products
  • Interleukin 13 (IL13) - Drug Profiles
  • Asthma
  • Interleukin
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Interleukin 12 Receptor (IL12R) Overview
  • Interleukin 12 Receptor (IL12R) - Drug Profiles
  • Interleukin
  • Therapy
  • United States
  • Product Initiative
  • Neumedicines Inc.
  • Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Pipeline Products Glance
  • Interleukin 15 Receptor Subunit Alpha (CD215 or IL15RA) - Dormant Projects
  • Cancer
  • Hospital
  • Interleukin
  • Therapy
  • Altor BioScience Corporation
  • VACCINE TO TARGET INTERLEUKIN 4 AND INTERLEUKIN 13 FOR ALLERGIES - DRUG PROFILE
  • Interleukin 13 (IL13) - Drug Profiles
  • Asthma
  • Interleukin
  • Monoclonal Antibody
  • United States
  • Product Initiative
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Dormant Projects
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Therapeutics Assessment
  • Cancer
  • Interleukin
  • United States
  • Product Initiative
  • ARMO Biosciences, Inc.
  • Interleukin 17A (Cytotoxic T Lymphocyte Associated Antigen 8 or CTLA8 or IL17A) Overview
  • INTERLEUKIN 17A (CYTOTOXIC T LYMPHOCYTE ASSOCIATED ANTIGEN 8 OR CTLA8 OR IL17A) - PRODUCTS UNDER DEVELOPMENT BY INDICATION
  • Autoimmune Disease
  • Interleukin
  • United States
  • Product Initiative
  • Novartis AG
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2016
  • DISCONTINUED PRODUCTS, H2 2016
  • Cytokine
  • Interleukin
  • United States
  • Product Initiative
  • Dompe Farmaceutici S.p.A.
  • Interleukin 15 (IL15) - Dormant Projects
  • Interleukin 15 (IL15) - Discontinued Products
  • Interleukin
  • Therapy
  • United States
  • World
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2016
  • UNKNOWN STAGE PRODUCTS
  • Biosimilar
  • Interleukin
  • Monoclonal Antibody
  • Therapy
  • OncoSec Medical Incorporated
  • DORMANT PROJECTS, H2 2016
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • Hospital
  • Interleukin
  • United States
  • Product Initiative
  • OncoSec Medical Incorporated

Interleukin Genetics, Inc.

  • Interleukin
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Dormant Projects
  • Interleukin 10 (Cytokine Synthesis Inhibitory Factor or CISF or IL10) - Discontinued Products
  • Cytokine
  • Interleukin
  • Therapy
  • United States
  • Product Initiative
  • Clinical Trial profile. 27 Trial Title
  • Target
  • Clinical Trial
  • Interleukin
  • Pharmaceutical
  • Respiratory Disease
  • Aradigm Corporation
  • Clinical Trial profile. 163 Trial Title
  • Clinical Trial profile. 105 Trial Title
  • Clinical Trial
  • Interleukin
  • Monoclonal Antibody
  • Ophthalmology
  • Novartis AG